ArticleContemporary clinical trials communications2023

Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome.

Carl B Shanholtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.